Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil transdermal patch versus oral donepezil in mild to moderate Alzheimer's disease
ACTRN12617001066370Phase 3Recruiting
- Sponsor
- Caidya
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing IPI-301 transdermal patch arm with Aricept oral tablet arm (2 arms). Primary endpoints: Change in Alzheimer's Disease Assessment Scale-Cognitive subscale and Clinician's Interview-Based Impression of Change Plus Caregiver Input. Started Oct 2017; status: recruiting.
02
Drugs
IPI-301donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on ACTRN12617001066370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001066370.